Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease.

Abstract:

BACKGROUND:Chronic graft-versus-host disease is a common late complication of allogeneic hematopoietic stem cell transplantation. Corticosteroids are the standard initial treatment. Second-line treatment has not been well defined. We evaluated the effectiveness and safety of low doses of alemtuzumab plus low doses of rituximab in the treatment of steroid-refractory chronic graft-versus-host disease. DESIGN AND METHODS:Ten men and 5 women were prospectively included in the study. All patients received one cycle of subcutaneous alemtuzumab 10 mg/day/3 days and intravenous rituximab 100 mg on Days +4, +11, +18 and +25. The therapeutic response was measured on Days +30, +90 and +365 of the protocol. RESULTS:Median age was 41 years. The main site involved was the oral mucosa (86.7%) followed by the eyes (66.7%), liver (60%), skin (53%), lungs (13.3%) and intestinal tract (6.7%). The overall response was 100% at Day +30 evaluation: 10 patients (67%) had partial remission, 5 (33%) had complete remission. At Day +90 evaluation, 7 (50%) patients had partial remission, 4 (28%) had complete remission; 3 (21%) had relapsed chronic graft-versus-host disease and one patient did not reach the evaluation time point. So far, 5 patients have reached the Day +365 follow-up evaluation; 2 (40%) had partial remission, 2 had complete remission and one experienced chronic graft-versus-host disease progression. Adverse effects were mainly infections in 67% of patients; these were all quickly solved, except for one patient who died from pneumonia. CONCLUSIONS:This combination therapy appears to be an efficacious and safe treatment for steroid-refractory chronic graft-versus-host disease. Longer follow up to determine the durability of response and survival is required (ClinicalTrials.gov: NCT01042509).

journal_name

Haematologica

journal_title

Haematologica

authors

Gutiérrez-Aguirre CH,Cantú-Rodríguez OG,Borjas-Almaguer OD,González-Llano O,Jaime-Pérez JC,Solano-Genesta M,Gómez-Guijosa M,Mancias-Guerra C,Tarin L,Gómez-Almaguer D

doi

10.3324/haematol.2011.054577

subject

Has Abstract

pub_date

2012-05-01 00:00:00

pages

717-22

issue

5

eissn

0390-6078

issn

1592-8721

pii

haematol.2011.054577

journal_volume

97

pub_type

杂志文章
  • Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.

    abstract::Interactions between chronic lymphocytic leukemia (CLL) B cells and the bone marrow (BM) microenvironment play a major function in the physiopathology of CLL. Extracellular vesicles (EVs), which are composed of exosomes and microparticles, play an important role in cell communication. However, little is known about th...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2016.163337

    authors: Crompot E,Van Damme M,Pieters K,Vermeersch M,Perez-Morga D,Mineur P,Maerevoet M,Meuleman N,Bron D,Lagneaux L,Stamatopoulos B

    更新日期:2017-09-01 00:00:00

  • Cytogenetic characterization of acute myeloid leukemia in Shwachman's syndrome. A case report.

    abstract::We report on a case of acute myeloid leukemia in a 17-year old boy affected by Shwachman Diamond syndrome (SDS). Conventional cytogenetics at diagnosis revealed an abnormal clone with complex karyotypic changes including typical myeloid aberrations, such as monosomy 5, tetrasomy of chromosome 8, trisomy 9, and deletio...

    journal_title:Haematologica

    pub_type: 杂志文章,评审

    doi:

    authors: Spirito FR,Crescenzi B,Matteucci C,Martelli MF,Mecucci C

    更新日期:2000-11-01 00:00:00

  • Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.

    abstract:BACKGROUND AND OBJECTIVES:Treatment of acute myeloid leukemia (AML) in older patients remains unsatisfactory. The BGMT 95 trial for older patients set out to improve the outcome of these patients by adding a third drug (lomustine) to a 5+7 idarubicin and cytarabine schedule at induction and evaluating intermediate-dose...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.3324/haematol.11068

    authors: Pigneux A,Perreau V,Jourdan E,Vey N,Dastugue N,Huguet F,Sotto JJ,Salmi LR,Ifrah N,Reiffers J

    更新日期:2007-10-01 00:00:00

  • Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.

    abstract::We report on the data collected in the Italian Registry of acquired haemophilia (AH) in 2001. Recombinant activated factor VII (rFVIIa) was selected as first-line therapy in 19 bleeding episodes because of their severity and as salvage in one case. Bleeding was controlled in 90% of the episodes, indicating the efficac...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Baudo F,de Cataldo F,Gaidano G,Italian registry of acquired hemophilia.

    更新日期:2004-06-01 00:00:00

  • Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.

    abstract::Double umbilical cord blood transplantation is increasingly applied in the treatment of adult patients with high-risk hematological malignancies and has been associated with improved engraftment as compared to that provided by single unit cord blood transplantation. The mechanism of improved engraftment is, however, s...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2014.106690

    authors: Somers JA,Braakman E,van der Holt B,Petersen EJ,Marijt EW,Huisman C,Sintnicolaas K,Oudshoorn M,Groenendijk-Sijnke ME,Brand A,Cornelissen JJ

    更新日期:2014-11-01 00:00:00

  • Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

    abstract:BACKGROUND:Paroxysmal nocturnal hemoglobinuria (PNH) is associated with an increased risk of thrombosis through unknown mechanisms. DESIGN AND METHODS:We studied 23 patients with PNH, before and after five and 11 weeks of treatment with eculizumab. We examined markers of thrombin generation and reactional fibrinolysis...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:10.3324/haematol.2009.016121

    authors: Helley D,de Latour RP,Porcher R,Rodrigues CA,Galy-Fauroux I,Matheron J,Duval A,Schved JF,Fischer AM,Socié G,French Society of Hematology.

    更新日期:2010-04-01 00:00:00

  • Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.

    abstract:BACKGROUND AND OBJECTIVES:Bone lesions often occur in multiple myeloma (MM), but no tests have proven useful in identifying patients with increased risk. Bone marker assays and bone densitometry are non-invasive methods that can be used repeatedly at low cost. This study was performed to evaluate these methods in predi...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Abildgaard N,Brixen K,Eriksen EF,Kristensen JE,Nielsen JL,Heickendorff L

    更新日期:2004-05-01 00:00:00

  • Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites.

    abstract::Mucosa-associated lymphoid tissue (MALT) lymphoma originates from a background of diverse chronic inflammatory disorders at various anatomic sites. The genetics underlying its development, particularly in those associated with autoimmune disorders, is poorly characterized. By whole exome sequencing of 21 cases of MALT...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2018.191601

    authors: Moody S,Thompson JS,Chuang SS,Liu H,Raderer M,Vassiliou G,Wlodarska I,Wu F,Cogliatti S,Robson A,Ashton-Key M,Bi Y,Goodlad J,Du MQ

    更新日期:2018-08-01 00:00:00

  • Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients.

    abstract::We report on five Caucasian patients with congenital polycythemia and mutations of the von Hipple-Lindau (VHL) gene: a compound heterozygote for the novel exon 1 (VHL 235C->T) and previously reported VHL 562C->G mutations; three homozygotes for Chuvash VHL 598C->T mutation; and a heterozygote for VHL 523->G mutation w...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Bento MC,Chang KT,Guan Y,Liu E,Caldas G,Gatti RA,Prchal JT

    更新日期:2005-01-01 00:00:00

  • Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.

    abstract:BACKGROUND AND OBJECTIVES:There are no widely accepted criteria for the definition of hematopoietic stem cell transplant -associated microangiopathy (TAM). An International Working Group was formed to develop a consensus formulation of criteria for diagnosing clinically significant TAM. DESIGN AND METHODS:The particip...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.10699

    authors: Ruutu T,Barosi G,Benjamin RJ,Clark RE,George JN,Gratwohl A,Holler E,Iacobelli M,Kentouche K,Lämmle B,Moake JL,Richardson P,Socié G,Zeigler Z,Niederwieser D,Barbui T,European Group for Blood and Marrow Transplantation.,E

    更新日期:2007-01-01 00:00:00

  • Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia.

    abstract::Chronic lymphocytic leukemia is a disease with up-regulated expression of the transmembrane tyrosine-protein kinase ROR1, a member of the Wnt/planar cell polarity pathway. In this study, we identified COBLL1 as a novel interaction partner of ROR1. COBLL1 shows clear bimodal expression with high levels in chronic lymph...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2017.178699

    authors: Plešingerová H,Janovská P,Mishra A,Smyčková L,Poppová L,Libra A,Plevová K,Ovesná P,Radová L,Doubek M,Pavlová Š,Pospíšilová Š,Bryja V

    更新日期:2018-02-01 00:00:00

  • Expression of multidrug resistance gene (MDR-1) in human normal leukocytes.

    abstract:BACKGROUND:The mdr-1 gene, which codes for a 170-kd transmembrane glycoprotein (P170), is frequently overexpressed in multidrug resistant (MDR) tumor cell lines and in spontaneous tumors, including leukemia and lymphoma. However, it is also constitutively expressed as a normal gene in normal tissues. METHODS:We used h...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Damiani D,Michieli M,Michelutti A,Geromin A,Raspadori D,Fanin R,Savignano C,Giacca M,Pileri S,Mallardi F

    更新日期:1993-01-01 00:00:00

  • Fluorescence in situ hybridization analysis of minimal residual disease and the relevance of the der(9) deletion in imatinib-treated patients with chronic myeloid leukemia.

    abstract::Forty-six patients with chronic myeloid leukemia receiving imatinib mesylate (39 in chronic phase, one in accelerated phase, and six in blastic crisis), were studied for a 20-62 month follow-up period by cytogenetics and fluorescence in situ hybridization using dual-color, dual-fusion BCR and ABL probes. This approach...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Calabrese G,Fantasia D,Di Gianfilippo R,Stuppia L,Di Lorenzo R,Palka G

    更新日期:2006-07-01 00:00:00

  • Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.

    abstract:BACKGROUND AND OBJECTIVES:In multiple myeloma (MM), the mechanisms used by plasma cells to invade locally and metastasize are thought to be similar to those developed by solid tumors and include cell proliferation and secretion of extracellular matrix (ECM) degrading enzymes following adhesion to ECM proteins. We studi...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Ria R,Vacca A,Ribatti D,Di Raimondo F,Merchionne F,Dammacco F

    更新日期:2002-08-01 00:00:00

  • Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.

    abstract:BACKGROUND:Routine electrophoretic analysis fails to detect a monoclonal component (MC) in a considerable portion of AL amyloidosis patients. We investigated whether the combination of immunofixation (IF) on agarose gel electrophoresis and bone marrow plasma cell (BMPC) light chain kappa/lambda ratio analysis could con...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Perfetti V,Garini P,Vignarelli MC,Marinone MG,Zorzoli I,Merlini G

    更新日期:1995-09-01 00:00:00

  • NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.

    abstract:BACKGROUND AND OBJECTIVES:NAD(P)H:quinone oxidoreductase 1 (NQO1) is an enzyme that protects cells against mutagenicity from free radicals and toxic oxygen metabolites. The gene coding for NQO1 is subject to a genetic polymorphism at nucleotide position 609 (C-->T) of the human NQO1 cDNA. Heterozygous individuals (C/T)...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Kracht T,Schrappe M,Strehl S,Reiter A,Elsner HA,Trka J,Cario G,Viehmann S,Harbott J,Borkhardt A,Metzler M,Langer T,Repp R,Marschalek R,Welte K,Haas OA,Stanulla M

    更新日期:2004-12-01 00:00:00

  • An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia.

    abstract::Not available. ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2020.266320

    authors: Tanaka Y,Yeoh AEJ,Moriyama T,Li CK,Kudo K,Arakawa Y,Buaboonnam J,Zhang H,Liu HC,Ariffin H,Chen Z,Kham SKY,Nishii R,Hasegawa D,Fujimura J,Keino D,Kondoh K,Sato A,Ueda T,Yamamoto M,Taneyama Y,Hino M,Takagi M,O

    更新日期:2021-01-28 00:00:00

  • Severe hematological side effects following Rituximab therapy in children.

    abstract::Rituximab use in severe auto-immune diseases has recently increased. Scattered reports of opportunistic infections were the only reported serious side effects related to rituximab in pediatric patients .Here, we report transient severe acute thrombocytopenia and neutropenia respectively a few days after rituximab infu...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Larrar S,Guitton C,Willems M,Bader-Meunier B

    更新日期:2006-08-01 00:00:00

  • European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.

    abstract::Multiple myeloma management has undergone profound changes in the past thanks to advances in our understanding of the disease biology and improvements in treatment and supportive care approaches. This article presents recommendations of the European Myeloma Network for newly diagnosed patients based on the GRADE syste...

    journal_title:Haematologica

    pub_type: 杂志文章,实务指引

    doi:10.3324/haematol.2013.099358

    authors: Engelhardt M,Terpos E,Kleber M,Gay F,Wäsch R,Morgan G,Cavo M,van de Donk N,Beilhack A,Bruno B,Johnsen HE,Hajek R,Driessen C,Ludwig H,Beksac M,Boccadoro M,Straka C,Brighen S,Gramatzki M,Larocca A,Lokhorst H,Magar

    更新日期:2014-02-01 00:00:00

  • Expected number of childhood cancers in Italy from 2001 to 2015.

    abstract::The total number of children with incident cancer in Italy has never been specifically estimated. Specialized population-based Childhood Cancer Registries have only been operating in Piedmont (CCRP) and in the Marche region, while general population cancer registries cover about 20% of the Italian population. The numb...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.11310

    authors: Baussano I,Maule MM,Dama E,Dalmasso P,Mosso ML,Galzerano M,Merletti F,Magnani C,Pastore G

    更新日期:2007-09-01 00:00:00

  • Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century.

    abstract::Treatment of adults with acute myeloblastic leukemia has changed substantially over the past two decades. Currently available estimates of survival do not reflect results from present state-of-the-art treatment due to a lag between the availability of new treatments and data concerning their effect on survival on the ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.12304

    authors: Pulte D,Gondos A,Brenner H

    更新日期:2008-04-01 00:00:00

  • Transient pancytopenia after non-A non-B non-C acute hepatitis preceding acute lymphoblastic leukemia.

    abstract::Transient pancytopenia preceding childhood acute lymphoblastic leukemia (ALL) is an unfrequent but well-known event. The association of this preleukemic syndrome with hepatitis is extremely rare, with only two such cases having been published in the literature. We report the case of a 16-year-old boy who was diagnosed...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Rafel M,Cobo F,Cervantes F,Bosch F,Campo E,Montserrat E

    更新日期:1998-06-01 00:00:00

  • Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.

    abstract:BACKGROUND:Acute myeloid leukemia is a clonal hematopoietic malignant disease; about 45-50% of cases do not have detectable chromosomal abnormalities. Here, we identified hidden genomic alterations and novel disease-related regions in normal karyotype acute myeloid leukemia/myelodysplastic syndrome samples. DESIGN AND...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.13024

    authors: Akagi T,Ogawa S,Dugas M,Kawamata N,Yamamoto G,Nannya Y,Sanada M,Miller CW,Yung A,Schnittger S,Haferlach T,Haferlach C,Koeffler HP

    更新日期:2009-02-01 00:00:00

  • Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction.

    abstract:BACKGROUND AND OBJECTIVES:Storage pool diseases (SPD) are heterogeneous disorders associated with an abnormal presence of intraplatelet granules, which cause mild to moderate bleeding diathesis. We investigated signaling through tyrosine phosphorylation of proteins occurring in platelets with total or partial absence o...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Arderiu G,Díaz-Ricart M,Domenech P,Escolar G,Ordinas A,Pujol-Moix N

    更新日期:2002-06-01 00:00:00

  • Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients.

    abstract:BACKGROUND AND OBJECTIVES:To assess the efficacy and the toxic profile of gemcitabine, a novel pyrimidine antimetabolite active against several solid tumors, we carried out a study in heavily pretreated Hodgkin's disease (HD) patients. DESIGN AND METHODS:From May 1997 to January 1999, 14 pretreated patients (10 relaps...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章

    doi:

    authors: Zinzani PL,Bendandi M,Stefoni V,Albertini P,Gherlinzoni F,Tani M,Piccaluga PP,Tura S

    更新日期:2000-09-01 00:00:00

  • Ceftriaxone and amikacin as single daily dose in the empiric therapy for febrile episodes in neutropenic patients.

    abstract::One hundred thirty-three febrile episodes in 115 neutropenic patients with hematologic malignancies were empirically treated with ceftriaxone and amikacin in a single daily dose. An indwelling central venous catheter (CVC) was present in 44 cases. Septicemia was documented in 18 (41%) patients with CVC (13 gram-positi...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Martino P,Girmenia C,Raccah R,Micozzi A,Cimino G,Mandelli F

    更新日期:1990-01-01 00:00:00

  • Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.

    abstract:BACKGROUND:Classical Hodgkin's lymphoma is characterized by a minority of neoplastic cells surrounded by a heterogeneous background population of non-neoplastic cells including lymphoma-associated macrophages. High levels of expression of both the monocyte/macrophage lineage-associated antigens CD68 and CD163 have been...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2010.031542

    authors: Kamper P,Bendix K,Hamilton-Dutoit S,Honoré B,Nyengaard JR,d'Amore F

    更新日期:2011-02-01 00:00:00

  • Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells.

    abstract:BACKGROUND AND OBJECTIVES:Patients with chronic renal failure show signs of accelerated atherosclerosis and high cardiovascular morbidity and mortality. Recent investigations indicate that uremia is associated with endothelial dysfunction and a microinflammatory state. We assessed changes in the expression of adhesion ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Serradell M,Díaz-Ricart M,Cases A,Zurbano MJ,López-Pedret J,Arranz O,Ordinas A,Escolar G

    更新日期:2002-10-01 00:00:00

  • Fibrinogen survival and fibrinopeptide A in acute leukemia.

    abstract::BACKGROUND. Hypofibrinogenemia and increased fibrin(ogen) degradation products in acute leukemia have been attributed to intravascular thrombin generation triggered by leukemic cells. However, the strict relationship between fibrinogen catabolism and turnover of fibrinopeptide A (FPA), which is a sensitive and specifi...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Castaman G,Galloni E,Dri AV,Rodeghiero F

    更新日期:1993-11-01 00:00:00

  • Verification and comparison of two different predictive equations in Hodgkin's disease.

    abstract:BACKGROUND AND OBJECTIVE:In recent years, two predictive equations to estimate median expected survival at diagnosis for patients affected with Hodgkin's disease have been developed at the University of Pavia Medical School. The present retrospective work was aimed at testing correlation between mean survival estimated...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Bettini R,Tonolini M,Maccianti E

    更新日期:1997-05-01 00:00:00